Search
for
Sort by
Research 121–150 of 1000+
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- SNP variation in male pattern hair loss in Russians with different dihydrotestosterone levels
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors
- Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone
- Association of Dihydrotestosterone with Crowing Complexity Traits in Kokok Balenggek Roosters
- Estudio comparativo de dos complementos alimenticios inhibidores de la 5a-reductasa en la alopecia androgénica femenina
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Concomitant immobilization of androgen receptors and 5α- reductase in androgenic alopecia
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Testosterone metabolite nonessential for androgen effects
- Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Finasteride in the Treatment of Hirsutism
- Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES